WORLDglobal
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India - Reuters
Single source
Updated 3 hours ago
First seen March 20, 2026 03:05:11Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India Reuters